Stock CALTX CALLIDITAS THERAPEUTICS AB
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Calliditas Therapeutics AB

Equities

CALTX

SE0010441584

Real-time Estimate Cboe Europe
Other stock markets
 11:25:00 2024-05-28 am EDT 		5-day change 1st Jan Change
202.5 SEK +78.26% Intraday chart for Calliditas Therapeutics AB +74.48% +59.24%
May. 24 HC Wainwright Cuts Calliditas Therapeutics Price Target to $45 From $50, Maintains Buy Rating MT
May. 23 Tech Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Calliditas Therapeutics Announces Executive Changes
CI
Calliditas Announces Additions to the Management Team, Effective 1 January 2024
CI
Calliditas Therapeutics' Nomination Committee Composition for the Agm 2024
CI
Calliditas Therapeutics AB Announces Board Changes
CI
Calliditas Therapeutics nomination committee composition for the AGM 2023
AQ
Calliditas Therapeutics' nomination committee composition for the AGM 2023
AQ
Calliditas Therapeutics AB Announces Nomination Committee Composition for the Agm 2023
CI
Calliditas Therapeutics AB Announces Executive Appointments
CI
Calliditas Therapeutics AB Announces Board Changes
CI
Calliditas Therapeutics AB (publ.) publishes the nomination committee’s composition for the AGM in 2022 - Form 6-K
PU
Calliditas Therapeutics? Nomination Committee for the AGM 2022
CI
Calliditas Therapeutics' nomination committee for the AGM 2022
AQ
Calliditas Therapeutics AB Promotes Andrew Udell to President, North America
CI
Calliditas Therapeutics AB Announces Executive Appointments
CI
Calliditas Therapeutics : rsquo; nomination committee for the AGM 2
PU
Calliditas Therapeutics : nomination committee for the AGM 2021
AQ
Calliditas Therapeutics' : nomination committee for the AGM 2021
AQ
Calliditas Therapeutics AB Appoints Jonathan Schur as Group General Counsel
CI
Calliditas Therapeutics AB Announces Executive Changes
CI
Calliditas Therapeutics AB Elects Molly Henderson as Member of the Board of Directors
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CALTX Stock
  4. News Calliditas Therapeutics AB
  5. Insiders